A series of 32 melanoma cell lines - eight derived from surgically-excised primary melanomas, seventeen from cutaneous or lymph nodal metastases - were firstly investigated for mutations in the three main genes (BRAF, NRAS, and CDKN2A) involved in melanoma pathogenesis (Table 1). This evidence concerns the gene CDKN2A and melanoma.